Skip to main content
Log in

Prostataobstruktionsassoziierte Symptome der unteren Harnwege

Behandlung mit Anticholinergika in Kombination mit Alpha-Blockern

Benign prostatic obstruction-associated symptoms of the lower urinary tract

Treatment with anticholinergics in combination with alpha-blockers

  • Evidenzbasierte Medizin
  • Published:
Der Urologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Brasure M, MacDonald R, Dahm P et al (2016) Newer medications for lower urinary tract symptoms attributed to benign prostatic hyperplasia: a review. Comparative effectiveness review, Bd. 178

    Google Scholar 

  2. D’Ancona C, Haylen B, Oelke M et al (2019) On behalf of the Standardisation Steering Committee ICS and the ICS Working Group on Terminology for Male Lower Urinary Tract & Pelvic Floor Symptoms and Dysfunction. Neurourol Urodyn 38(2):433–477

    Article  Google Scholar 

  3. European Association of Urology (2021) EAU guideline on management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO)

    Google Scholar 

  4. Gormley EA, Lightner DJ, Faraday M et al (2015) Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. J Urol 193(5):1572–1580

    Article  Google Scholar 

  5. Kim HJ, Sun HY, Choi H et al (2017) Efficacy and safety of initial combination treatment of an alpha blocker with an anticholinergic medication in benign prostatic hyperplasia patients with lower urinary tract symptoms: updated meta-analysis. PLoS ONE 12:e169248

    Article  Google Scholar 

  6. Lee SH, Byun SS, Lee SJ et al (2014) Effects of initial combined tamsulosin and solifenacin therapy for overactive bladder and bladder outlet obstruction secondary to benign prostatic hyperplasia: a prospective, randomized, multicenter study. Int Urol Nephrol 46(3):523–529

    Article  Google Scholar 

  7. Reynard JM (2004) Does anticholinergic medication have a role for men with lower urinary tract symptoms/benign prostatic hyperplasia either alone or in combination with other agents? Curr Opin Urol 14(1):13–16

    Article  Google Scholar 

  8. Wang YC, Chen YL, Huang CC et al (2019) Cumulative use of therapeutic bladder anticholinergics and the risk of dementia in patients with lower urinary tract symptoms: a nationwide 12-year cohort study. BMC Geriatr 18:380

    Article  Google Scholar 

  9. Xin Z, Huang Y, Lu J et al (2013) Addition of antimuscarinics to alpha-blockers for treatment of lower urinary tract symptoms in men: a meta-analysis. Urology 82(2):270–277

    Article  Google Scholar 

  10. Yu ZJ, Yan HL, Xu FH et al (2020) Efficacy and side effects of drugs commonly used for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia. Front Pharmacol 11:658

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sandra Schönburg FEBU.

Ethics declarations

Interessenkonflikt

S. Schönburg: Referententätigkeit: Allergan, A.M.I., AstraZeneca, Boston Scientific. Beratertätigkeit: Omega Pharma. Die Autorin versichert, dass betreffs der im Artikel genannten Thematik keine Interessenskonflikte bestehen.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schönburg, S. Prostataobstruktionsassoziierte Symptome der unteren Harnwege. Urologe 60, 1188–1191 (2021). https://doi.org/10.1007/s00120-021-01617-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-021-01617-2

Navigation